Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.
—
Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.
—
Daily adjusted close
Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.